BNC Korea Co., Ltd. (256840) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for BNC Korea Co., Ltd. (256840:KRX), powered by AI.

Current Price
₩4,150
P/E Ratio
20.8
Market Cap
283.8B
Sector
Healthcare
What is the BNC Korea Co., Ltd. stock price forecast?

BNC Korea Co., Ltd. is currently trading at ₩4,150. View real-time AI analysis on Alpha Lenz.

What is BNC Korea Co., Ltd. insider trading activity?

View the latest insider trading data for BNC Korea Co., Ltd. on Alpha Lenz.

What is BNC Korea Co., Ltd.'s P/E ratio?

BNC Korea Co., Ltd.'s P/E ratio is 20.8.

BNC Korea Co., Ltd.

KRX · 256840
₩4,150
Ask about BNC Korea Co., Ltd.'s future dividend policy...
Alpha Chat Insight

BNC Korea Co., Ltd. trades at a P/E of 20.8 (fair value) with modest ROE of 6.1%. 3Y revenue CAGR of 52.3% highlights clear growth momentum.

Ask for details

Company Overview

BNC Korea Co., Ltd. is a prominent player in the manufacturing and distribution sector, primarily focused on providing high-quality medical supplies and beauty products. The company embodies a strong commitment to innovation and excellence, catering to a diverse range of industries that include healthcare, cosmetics, and personal care. With an emphasis on developing state-of-the-art technological solutions, BNC Korea Co., Ltd. enhances the efficacy and safety of its product offerings. The firm has established a significant presence in the international market, building a reputation for reliability and customer satisfaction. Leveraging advanced research and development facilities, BNC Korea Co., Ltd. continually expands its product lines to address the growing demand for effective and accessible medical products. Its deep understanding of the healthcare industry's needs positions the company as an essential contributor to global wellness and beauty trends. Through strategic partnerships and a robust distribution network, BNC Korea Co., Ltd. ensures that its innovative solutions reach a broad audience, reinforcing its role as a crucial player in the financial markets, particularly in sectors related to health and beauty product manufacturing.

CEO최완규
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees242

Company Statistics

FY 2024

Profile

₩283,838,776,900Market Cap
₩89,229,997,630Revenue
68.39MShares Out
242Employees

Margins

46.79%Gross
34.98%EBITDA
15.62%Operating
17.54%Pre-Tax
14.87%Net

Valuation

20.80P/E
1.20P/B
3.10EV/Sales
6.64EV/EBITDA
-201.01P/FCF

Growth (CAGR)

52.32%Rev 3Yr
38.25%Rev 5Yr
N/AOp Inc 3Yr
56.63%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

5.27%ROA
6.06%ROE
6.35%ROIC

Financial Health

₩90,799,795,330Cash & Cash Equivalents
₩-60,215,717,120Net Debt
12.93%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

BNC Korea Co., Ltd. (ticker: 256840) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 242 employees. Market cap is $283.8B.

The current price is ₩4,150 with a P/E ratio of 20.8x and P/B of 1.2x.

ROE is 6.06% and operating margin is 15.62%. Annual revenue is $89.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
BNC Korea Co., Ltd. (Healthcare) Stock Forecast & Analysis ₩4,150 | Alpha Lenz